AVBP - ArriVent BioPharma, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
ArriVent BioPharma, Inc. Common Stock
IPO Date: January 26, 2024
Sector: Healthcare
Industry: Biotech
Market Cap: $1.42B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.69 | 2.96%
Avg Daily Range (30 D): $0.61 | 2.03%
Avg Daily Range (90 D): $0.74 | 2.44%
Institutional Daily Volume
Avg Daily Volume: .25M
Avg Daily Volume (30 D): .35M
Avg Daily Volume (90 D): .41M
Trade Size
Avg Trade Size (Sh.): 57
Avg Trade Size (Sh.) (30 D): 54
Avg Trade Size (Sh.) (90 D): 58
Institutional Trades
Total Institutional Trades: 620
Avg Institutional Trade: $1.68M
Avg Institutional Trade (30 D): $1.93M
Avg Institutional Trade (90 D): $2.06M
Avg Institutional Trade Volume: .07M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.81M
Avg Closing Trade (30 D): $2.39M
Avg Closing Trade (90 D): $2.74M
Avg Closing Volume: 71.91K
 
News
May 7, 2026 @ 12:00 PM
ArriVent Announces IND Clearance for Novel Tetrava...
Source: Na
Mar 17, 2026 @ 9:00 PM
ArriVent to Present Two Preclinical Posters on the...
Source: Na
Feb 5, 2026 @ 2:35 PM
$207B Market Shift: The Race for Fast Track Approv...
Source: Prnewswire
Jan 12, 2026 @ 3:35 PM
Fast-Tracking the $537B Cancer Cure: How Accelerat...
Source: Prnewswire
Dec 22, 2025 @ 1:00 PM
ArriVent Announces First Patient Dosed in Global P...
Source: Na
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-3.62 $-1.05 $-.96
Diluted EPS $-3.62 $-1.05 $-.96
Revenue $M $M $M
Gross Profit
Net Income / Loss $-163.74M $-49.89M $-43.32M
Operating Income / Loss $-175.94M $-52.69M $-46.11M
Cost of Revenue
Net Cash Flow $41.92M $92.58M $16.56M
PE Ratio